Britain's electricity system operator handed Palantir a UK power grid contract without inviting a rival bid. Less than six months earlier, a UK minister told Parliament the government was moving away from this kind of award.
The Financial Times reported the award on Sept. 8. The buyer is the National Energy System Operator, or NESO — the publicly owned body that has operated Great Britain's electricity system since October 2024. That launch date comes from the UK government's own announcement. NESO ran no competition. It leaned on a legal exemption that drops the duty to consider other suppliers when existing dependencies leave no alternative, per the FT's account.
For anyone holding Palantir Technologies (NASDAQ: PLTR), the instinct is to ask what the contract is worth. That is the wrong question here, and the arithmetic below shows why.
Why It Matters
The size of the invoice is not what makes this award worth reading about. Palantir is now large enough that no single British contract can bend its results — including UK contracts considerably larger than this one is likely to be.
What changed is the route in. A contract awarded with no competition is a statement about the buyer's options, not the seller's salesmanship. It says the buyer believes it has none. When that judgment recurs across unconnected parts of a government, it stops being a series of purchasing decisions. It becomes a description of dependence.
That dependence is the asset and the exposure at once. It is why the position is durable, and why political pushback, if it arrives, is likely to aim at the arrangement rather than the price.
The money cannot matter much
Palantir does not disclose the value of individual UK contracts. LineVest could not verify a figure for the NESO award from any published procurement notice, so this article does not carry one. But the company's largest known UK public contract sets a useful ceiling on the imagination.
The Ministry of Defence signed a three-year enterprise agreement with Palantir's UK unit worth £240.6 million (about $326 million), The Register reported in January 2026. Spread evenly, that is roughly £80 million a year.
All sterling figures in this article are converted at $1.3555 per pound. That is the Federal Reserve's H.10 reference rate for Aug. 28, 2026.
On that basis, the MoD agreement runs at about $109 million a year.
Now set that against the company's own outlook. Palantir guided to full-year 2026 revenue of $8.15 billion in the second-quarter press release it filed with the SEC. Divide the MoD run rate above by that guidance and the answer lands near 1.3%. That is LineVest's own arithmetic on two disclosed figures, not a market-share estimate — and again, the MoD deal is the large one.
Here is another way to feel the scale. Palantir booked $1.94 billion of revenue in the second quarter, across 91 days. That works out to roughly $21 million a day. The MoD's entire annual payment is worth about five days of company revenue.
A grid contract is probably smaller still, though no published figure confirms that. Whatever the figure turns out to be, it is unlikely to move guidance, and unlikely to appear as a line any shareholder can see. So the story is not revenue. The story is the door the contract came through.
What the exemption actually says
The exemption lives in the Procurement Act 2023, the law that governs UK public buying. Paragraph 6 of Schedule 5 permits a direct award in one narrow circumstance. The statute puts it this way:
"Due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and there are no reasonable alternatives to those goods, services or works."
Read that clause slowly. It does not ask whether a rival product exists somewhere in the market. It asks whether this particular buyer, as things actually stand today, could realistically switch. Those are two very different tests.
The distinction matters more than it first appears. A market test is relatively stable over time — competitors either exist or they do not. A switching test is not stable at all. It describes a relationship, and relationships deepen.
Every year a supplier stays in place, that second test tends to get easier to pass. Data models get built inside the platform. Dashboards get wired to it. Internal processes reorganize around how it behaves, and staff learn its quirks rather than a competitor's. None of this is sinister. It is what successful software adoption looks like everywhere.
But it has a procurement consequence. At some point, migrating can genuinely become impractical — and at that point, the law stops requiring a contest. The better the vendor performed in earlier years, the stronger its legal claim to the next award without bidding.
That is the mechanism worth watching, and it deserves stating plainly. A supplier that wins once on merit can win thereafter on inertia. Lawfully. With a documented justification that says so in writing.
A pattern, not an incident
Palantir has now taken at least three significant UK public contracts, and at least two of them were awarded without a competition.
In November 2023, NHS England awarded a Federated Data Platform contract. The award notice put the value at £182.2 million — about $247 million — and ran the contract to February 2027. That one went through a tender process; the two that followed did not.
In December 2025, the MoD used a defence and security exemption to hand over its follow-on agreement without a competition, The Register reported. Now a third public body has arrived at the same destination by a third route.
Each award was justified on its own terms, and each justification may well be sound in isolation. That is exactly what makes the sequence hard to challenge. Read together, though, the three describe something no individual notice does: a supplier that is becoming harder to replace across unrelated arms of the British state.
What the minister said in March
What has changed since LineVest last covered Palantir's UK exposure is the nature of the complaint, not just the number of contracts.
Previewing the company's second-quarter results on Aug. 3, this publication flagged one UK item under new risks: NHS England had been reprimanded on July 29 over an inaccurate disclosure involving Palantir patient data. At the time the problem looked contained. One agency, one dataset, one privacy question.
It reads differently now. The issue has moved out of health data and into energy infrastructure, and the complaint has shifted from privacy to procurement. Those are separate failure modes with separate constituencies, and the second one is harder for a company to answer. A privacy row can be met with better safeguards. A procurement row is about whether anyone else was allowed to compete.
On March 20, 2026, science minister Patrick Vallance was pressed by MPs over the Palantir contracts, The Register reported. He said he wanted to change how government buys technology, stressing "putting British companies there and procuring innovation here." Asked directly about the NHS arrangement, he was blunter. "We are not continuing," he said. "We are doing something very different."
Less than six months later, a public body awarded Palantir work with no competition at all.
Two caveats belong right here, and they are not small. Vallance was speaking about the NHS contract specifically, not about NESO. And one department genuinely cannot bind another — NESO is operationally independent of ministers, and is regulated by Ofgem, Britain's energy regulator, rather than run from Whitehall.
Still, the promise was framed as a change of direction rather than a single renegotiation. Directions are meant to apply broadly. A minister who says the government is "doing something very different" is describing policy, not paperwork.
Why a grid is a harder case than a hospital
The NHS dispute has been fought largely over patient privacy. A grid raises a different concern, and a considerably less emotive one.
NESO's job is to keep the lights on in real time. If its planning and operational decisions come to rest on one vendor's platform, the dependency stops being merely commercial. It becomes an operational fact about national infrastructure. That is the argument critics will reach for, and it requires nobody to dislike Palantir or object to its politics.
The reverse deserves equal weight. Running a national grid is genuinely difficult, and the pool of vendors with proven capability at that scale is small. NESO's claim that no reasonable alternative exists may simply be accurate. The exemption exists in law because such situations are real, not because someone wanted a loophole.
There is also a timing problem that has nothing to do with Palantir. NESO is young, it inherited a complex job, and it is under pressure to deliver quickly. Organizations in that position often choose the fast, defensible procurement path over the slow one.
What would make this reading wrong
The risk described here is political, and political risk is slow, noisy and frequently toothless.
If the NESO contract proves small, draws no sustained parliamentary interest and is never revisited, then this was an administrative footnote. Palantir's UK revenue is a modest slice of an international business that is itself far smaller than its US operations. A procurement row that generates headlines but cancels no contracts costs shareholders precisely nothing.
So the counter-argument should be stated without hedging. If no UK contract is ever actually cancelled or re-tendered, then this reading was noise dressed up as analysis, and the wire coverage will have been the more accurate guide.
The specific thing to watch
Two things will settle the question, and neither is far off.
The first is whether the NESO award draws a parliamentary response. Palantir's UK contracts have a consistent record of attracting questions without producing cancellations. The March exchange — in which Vallance said the government was "doing something very different" — is the clearest example: it was followed six months later, not preceded, by another no-bid award.
The second is renewal. Several existing Palantir UK agreements reach their stated end dates within the next two years. Whether those renewals go to open tender — or whether the no-reasonable-alternative argument is applied again — will say more about the direction of UK public procurement than any ministerial statement has.
